Experimental Drug Shows Promising Results For Men With Prostate Cancer - NY1

International Business Times

Experimental Drug Shows Promising Results For Men With Prostate Cancer NY1 An experimental drug seems to be improving outcomes in men with extremely advanced prostate cancer, and one of the city's top cancer centers is playing a key role in the research. NY1's Kafi Drexel filed the following report. Prostate Cancer Drug: How to Find Clinical Trials of Promising MedInternational Business Times Chemoprevention of prostate cancer: An updated view - AbstractUroToday Urine-Based Markers May Pinpoint Prostate Cancer Patients With Aggressive DiseaseCancer Network all 15 news articles »

FDA doubts benefits of Amgen drug for prostate cancer - GlobalPost

USA TODAY

FDA doubts benefits of Amgen drug for prostate cancer GlobalPost In May, a clinical trial by Amgen showed that Xgeva could also delay metastasis, or the spread of cancer to the bone, in patients with prostate cancer, "which could significantly extend its market potential," Pharma Times reported. FDA staff unsure about new use for Amgen's XgevaReuters FDA Reviewers Unsure about New Use for Amgen's XgevaHealth Aim (blog) Can Amgen Convince Docs to Recommend Approval?DailyFinance MedPage Today all 222 news articles »